Business
Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress
CHATHAM, N.J., March 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today
About this update from Tonix Pharmaceuticals Holding Corp.
[{"type":"text","content":"CHATHAM, N.J., March 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Zeil Rosenberg, M.D., M.P.H., Executive Vice President, Medical and Farooq Nasar, Ph.D., Senior Principal Investigator, both of Tonix Pharmaceuticals, will deliver oral presentations at the World Vaccine Congress, which will be held in Washington D.C., April 3 - 6, 2023. Copies of the Company’s presentations will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be found on the World Vaccine Congress website here. In addition, Sina Bavari, Ph.D., Executive Vice President, Infectious Disease Research and Development of Tonix Pharmaceuticals will be moderating a panel of key opinion leaders discussing Mpox and the challenges and opportunities in vaccine development. Oral Presentation Details Presenter:Zeil Rosenberg, M.D., M.P.H. (Tonix Pharmaceuticals) Title:A Live Attenuated Orthopoxvirus (Horsepox) Vaccine for Mpox and Smallpox Location:Walter E. Washington Convention Center, Washington D.C. Date:Wednesday April 5, 2023 Time:12:25 p.m. ET Oral Presentation Details Presenter:Farooq Nasar, Ph.D. (Tonix Pharmaceuticals) Title:The Development of Horsepox Virus as a Vaccine Platform: Evaluation of TNX-1800 as a SARS-CoV-2 Vaccine Location:Walter E. Washington Convention Center, Washington D.C. Date:Thursday April 6, 2023 Time:10:10 a.m. ET Panel Details Title:Mpox - Challenges and Opportunities in Vaccine Development Panel:Sina Bavari, Ph.D. (Tonix Pharmaceuticals); David Evans, Ph.D. (University of Alberta); Jose Esparza, M.D., Ph.D. (University of Maryland); Deborah Birx, M.D. (BGR Group); Michael Merchlinsky, Ph.D. (HHS/BARDA) Location:Walter E. Washington Convention Center, Washington D.C. Date:Thursday April 6, 2023 Time:11:30 a.m. ET Tonix Pharmaceuticals Holding Corp.* Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS portfolio includes both small molecules and biologics to treat pain...